In cancer, the role of DKK-1 is complex, with a growing body of evidence showing that it can either inhibit cancer metastases in ovarian cancer [9] and colorectal cancer [10] or promote cancer progression in osteosarcoma [11], breast cancer [12], and prostate cancer [13]. This evidence concerns the gene DKK1 and prostate carcinoma.